| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $241.5M | -4.2% |
| Cost of Revenue | $58.2M | +6.4% |
| Gross Profit | $183.3M | -7.2% |
| R&D Expense | $34.8M | -4.8% |
| SG&A Expense | $51.6M | +4.8% |
| Operating Income | -$224.3M | +68.4% |
| Interest Expense | $11.3M | -23.9% |
| Pre-tax Income | -$209.3M | +67.0% |
| Income Tax | -$10.0M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $163.6M | +55.3% |
| Short-term Investments | $17.3M | -90.7% |
| Accounts Receivable | $52.0M | -2.4% |
| Current Assets | $257.6M | -30.4% |
| Total Assets | $735.5M | -32.5% |
| Current Liabilities | $156.8M | -2.7% |
| Long-term Debt | $166.3M | -31.9% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $53.8M | -7.6% |
| Capital Expenditures | $16.7M | +35.5% |
| Investing Cash Flow | $153.9M | +682.7% |
| Financing Cash Flow | -$150.8M | -165.7% |
| Free Cash Flow | $37.1M | -19.2% |
| +76.5% |
| Net Income | -$138.9M | +66.4% |
| EPS (Basic) | -$1.30 | +63.3% |
| EPS (Diluted) | -$1.30 | +63.3% |
| Total Liabilities |
| $356.5M |
| -26.1% |
| Stockholders' Equity | $379.0M | -37.6% |